CD79A and colorectal carcinoma: Statistical analysis showed no significant difference on the number of CRC cases who tested positive for anti-ETBF IgG (lysate: P = 0.615; broth: P = 0.494) and IgA (P = 0.240) antibodies compared to their matched controls in both bacterial lysates and culture broths (Figure 3).